Aro Biotherapeutics Secures $41.5M in Series B Funding to Advance Tissue-Targeted Genetic Medicines
Key Highlights Aro Biotherapeutics raised $41.5M in a Series B funding round led by Cowen Healthcare Investments. Funding participants…
Browsing Tag
Aro Biotherapeutics
1 post